We are live on ! Find out more
WGS

Washington Growth Strategies Portfolio holdings

AUM $180M
1-Year Est. Return 31.73%
This Fund
S&P 500
This Quarter Est. Return
+18.9%
1 Year Est. Return
+31.73%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$180M
AUM Growth
+$27.1M
Cap. Flow
+$2.04M
Cap. Flow %
1.14%
Top 10 Hldgs %
64.9%
Holding
64
New
7
Increased
14
Reduced
5
Closed
2

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$404K
2
GILD icon
Gilead Sciences
GILD
+$403K
3
JNJ icon
Johnson & Johnson
JNJ
+$400K
4
NVDA icon
NVIDIA
NVDA
+$394K
5
TNA icon
Direxion Daily Small Cap Bull 3x ETF
TNA
+$262K

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$222K
2
FXI icon
iShares China Large-Cap ETF
FXI
+$197K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$165K
4
KYIV
Kyivstar Group
KYIV
+$150K
5
GLIN icon
VanEck India Growth Leaders ETF
GLIN
+$97.5K

Sector Composition

Rank Sector Weight
1 Healthcare 3.11%
2 Technology 1.12%
3 Financials 1.04%
4 Consumer Discretionary 1.01%
5 Real Estate 0.91%

No holdings matched the selected filter criteria.

1 2 3

Similar funds

FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
V
ViaWealth Leawood, Kansas $180M AUM 20.16% 1-Year Est. Return
RVM
Robinson Value Management San Antonio, Texas $180M AUM 24.17% 1-Year Est. Return

Washington Growth Strategies's Q2 2026 Portfolio in Review

As of Q2 2026, Washington Growth Strategies held 64 positions worth $180M, up 18% from $153M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Washington Growth Strategies's Q2 2026 filing shows 7 new, 14 increased, 5 reduced and 2 closed positions. Its largest new stake was Thermo Fisher Scientific: 842 shares worth $422K. The largest sale was SPDR Gold Trust, an estimated $222K.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.3% a quarter earlier, followed by Technology and Financials.

  • Washington Growth Strategies's largest Q2 2026 buy was Thermo Fisher Scientific: 842 shares worth $422K.
  • Washington Growth Strategies added most to NVIDIA in Q2 2026, an estimated $394K increase.
  • Washington Growth Strategies's biggest Q2 2026 reduction was iShares China Large-Cap ETF, cutting an estimated $197K.
  • Washington Growth Strategies fully exited SPDR Gold Trust in Q2 2026, selling an estimated $222K.
  • Washington Growth Strategies's ten largest holdings make up 65% of its $180M portfolio in Q2 2026.
  • Washington Growth Strategies opened 7 new positions and closed 2 in Q2 2026.
  • Washington Growth Strategies's portfolio value rose 18% quarter-over-quarter to $180M.

Based on Washington Growth Strategies's 13F filing for Q2 2026, filed 16 Jul 2026.